BCBP BCB BANCORP INC Insider Trading

Director Gerald Werdann purchased 4,400 shares of BCBP at $11.28, raising holdings to 12,122 shares (+57.0%)

Director Gerald Werdann purchased 4,400 shares at $11.28 on 2026-06-04, increasing his holdings by 57.0% from 7,722 to 12,122 shares. The stock has risen 11.7% over the prior 30 days and 37.7% over the prior 90 days, trading at $11.33 near its 52-week high of $11.71. However, the company reported negative net income over its most recent full fiscal year and currently carries an extremely elevated P/E of 283.25, suggesting either very thin near-term profitability or continued losses relative to current market valuation. This purchase occurs during a period of strong price momentum but against a backdrop of fundamental financial stress that warrants investor attention to the underlying business trajectory.

Director Mark D. Hogan buys 5,000 BCBP shares at $7.97; prior 5 BCBP buys all showed positive 90-day returns

Director Mark D. Hogan purchased 5,000 shares of BCB Bancorp at $7.97 on 2026-02-27, bringing his holdings to 103,352 shares. This open-market buy occurs at a price 20.4% below the 52-week high of $10.17, and follows a consistent pattern: across his prior 5 trades at BCBP, all 5 buys generated positive 90-day returns, ranging from +6.4% to +23.7%, indicating reliable timing accuracy at this specific ticker. His cross-ticker track record shows a 93.33% 90-day win rate across 15 prior buys with an average 90-day return of +14.0%, establishing a strong historical precedent for this insider's buy discipline. With a current P/E of 50.62 and net income of $4,262,000.00, BCBP trades at an elevated multiple, yet the insider's repeated accumulation at depressed price points suggests conviction in the company's intermediate-term prospects despite current valuation constraints.

Director Michael J Widmer buys 2,000 shares (2.0K) of BCBP at $8.40; holds 12,642 post-transaction

Widmer, a director, acquired 2,000 shares at $8.40, a 18.8% increase in his shareholding to 12,642 shares. The transaction occurs at a price that is 1.7% below the current market price of $8.26 and substantially below the 52-week high of $10.65 (trading 22.4% down from that peak). While the purchase follows recent upward momentum—30-day change of +4.6% and 90-day change of +7.4%—the stock's elevated P/E of 51.62 against net income of $4.3M and market cap of $142.3M warrants attention to whether valuations justify renewed director buying interest at this level.

Director Lyga Joseph bought 380 shares of BCBP at $7.70 (2 purchases, $2,926 total); stock now -42.8% from 52-week high. Cluster buy detected.

Lyga Joseph, a director at BCB Bancorp, made 2 separate purchases totaling 380 shares for $2,926.00 at $7.70 on 2025-06-13, expanding his position from 2,828 shares to 3,208 shares (+13.4%). The stock is currently trading at $7.75, down 42.8% from its 52-week high of $13.55 and down 21.2% over 90 days. The company reports negative net income of -$8,324,000.00, presenting fundamental headwinds. Notably, 2 other insiders also bought within the past 14 days, forming a cluster buy pattern. While the director's prior buy at this ticker in 2023 achieved a 90-day gain of +11.3%, the current trading environment reflects meaningful price deterioration since the 52-week peak, and the company's net loss warrants investor scrutiny of the underlying business condition.

Director Rizzo buys 2,000 shares of BCBP at $7.70; stock down 42.8% from 52-week high, but insider cluster and prior 90d timing pattern suggest contrarian positioning.

Director James G. Rizzo purchased 2,000 shares at $7.70, increasing holdings from 60.7K to 62.7K shares (+3.3%). This transaction occurs amid significant price weakness: BCBP has fallen 42.8% from its 52-week high of $13.55 and declined 21.2% over the past 90 days. However, two contextual factors warrant attention: (1) A cluster pattern is present—two other insiders purchased within the past 14 days—suggesting a coordinated response to depressed pricing, and (2) Rizzo's prior trades at this same ticker show a strong timing pattern, with three consecutive buy transactions (2024-06-06, 2024-06-07, 2024-06-14) all followed by positive 90-day returns (+20.8%, +22.7%, +25.5% respectively). Against this, the company's fundamentals are strained: net income is -$8.3M and the P/E is 29.81, which raises questions about the valuation rationale at current levels. The convergence of negative momentum (-21.2% in 90 days), weak earnings, and elevated insider buying activity creates a mixed signal that requires deeper analysis of the company's operational trajectory.

Director Hogan buys 10,000 shares of BCBP at $7.74; price now down -42.8% from 52-week high of $13.55, cluster of 3 insiders buying in 14 days.

Director Mark D. Hogan purchased 10,000 shares at $7.74 on 2025-06-13, increasing his holdings to 621,140 shares. The stock is currently trading at $7.75, down -42.8% from its 52-week high of $13.55 and -21.2% over the past 90 days. His prior trades at BCBP show strong timing: 4 of 4 measurable buys were well-timed at the 90-day mark, with returns ranging from +20.9% to +30.7%, and his cross-ticker track record shows 92.31% 90-day win rate across 14 prior buys averaging +14.6% 90-day return. The transaction is part of a cluster pattern with 2 other insiders also buying within the past 14 days. However, the company's fundamentals show a net loss of $-8,324,000.00 and a P/E of 29.81 at a market cap of $133,010,359.25, creating a tension between insider accumulation and deteriorating earnings.

Director Rizzo James G. buys 3,000 shares at $8.05 for $24,150.00 on 2025-05-27 at BCBP.

Rizzo made two separate purchases totaling 3,000 shares at $8.05 on the same day, bringing his holdings from 70.6K to 73.6K shares (+4.3%). The stock currently trades at $8.17, down 3.4% over 30 days and 19.3% over 90 days from a 52-week high of $13.55, placing it near the low end of its range. Notably, Rizzo's prior 4 purchases at BCBP (dating back to March 2024) showed strong 90-day outcomes (ranging +18.4% to +25.5%), with 4 of 5 prior same-ticker trades demonstrating favorable timing; however, his current purchase at depressed valuation within a recently weak 90-day window differs materially from the prior pattern. The company faces headwinds: net income of $-8.3M and a P/E ratio of 31.42 reflect earnings pressure despite his accumulation. This represents a substantial open-market commitment by a director when the stock is down significantly from recent highs, warranting close observation of whether this purchase precedes a financial or operational inflection.

Director Mark Hogan buys 10,000 BCBP shares at $8.04; timing consistent with his prior 4 well-timed buys, despite -39.7% from 52-week high.

Director Mark Hogan purchased 10,000 shares at $8.04, increasing his holdings by 11.3% to 98,352 shares. His prior five trades at BCBP show a strong timing pattern: four of those five buys achieved positive 90-day returns (20.9%, 23.7%, 23.5%, 30.7%), with only one purchase (2023-06-09) turning negative over 90 days. This current acquisition repeats that pattern at a price 39.7% below the 52-week high and while the stock is down 19.3% over 90 days, aligning with the company's reported net loss of $8.3M. The cross-ticker track record of 92.31% 90-day win rate on 13 prior buys suggests precision in entry timing, but the company's negative earnings environment and depressed valuation relative to historical levels warrant careful observation of whether this transaction precedes recovery or marks exposure to ongoing fundamental weakness.

Director VANARIA RAYMOND buys 1,000 shares of BCBP at $12.90; new director holdings established

VANARIA RAYMOND, a director of BCB BANCORP INC, purchased 1,000 shares at $12.90 on 2024-07-31, establishing an initial position from zero prior holdings. The transaction occurred at a price only 5.3% below the 52-week high of $13.62, suggesting the buy was not executed at a depressed valuation. The company trades at a P/E of 7.88 with a market cap of $215,019,717.88 ($215.0M), reflecting a modestly valued financial institution. The current price of $12.68 is -6.9% from the 52-week high and only 1.7% below the transaction price, indicating minimal price movement since the purchase. As an initial director position rather than an addition to existing holdings, this transaction documents a new board member's entry into equity ownership but provides limited visibility into broader board confidence given the small size relative to the company's capitalization.

Director Rizzo buys 1,000 shares of BCBP at $9.55; stock now $10.04, down 26.3% from 52-week high.

Rizzo James G., a director at BCB BANCORP INC, purchased 1,000 shares at $9.55 on 2024-06-14, adding 1.9% to his 53,518-share position. The transaction occurred as the stock trades at $10.04, off 7.2% over 30 days and 3.9% over 90 days, with the stock -26.3% from its 52-week high of $13.62. At his prior trades at BCBP, Rizzo's timing has been mixed: his February and March 2024 purchases at this ticker showed negative 90-day returns of -4.9% and -2.1%, respectively, and he had just made two purchases within the prior week (June 6 and June 7). His cross-ticker track record shows a 66.67% 90-day win rate with an average 90-day return of 15.0%, but same-ticker outcomes at BCBP do not yet demonstrate similar accuracy. The company trades at a P/E of 6.24 with $5.9M in net income and a $170.3M market cap, indicating a mature, lower-growth profile.